Enríquez E, Rangel A, Velasco CE, Basave MN, López-Rodríguez R

Language: Spanish
References: 15
Page: 603-608
PDF size: 220.78 Kb.

ABSTRACT

The authors report 7 cases of gangrenous ergotism (six women and one man) secondary to an overdose of ergotamine ingested in order to relieve migraine crisis. In all cases, patients presented symptoms and signs of severe arterial constriction confirmed by echography and angiography. Hallucinations were absent. Ergotamine ingestion was discontinued and treatment was based on vasodilators and sympathectomy. After treatment, all seven patients showed clinical improvement with disappearance of the vasospastic symptoms and signs, and an increase in the plethysmographic index of blood perfusion, measured by Doppler echography. These changes were observed even in a patient who lost two toes of the right foot. Although, none of the patients presented hallucinations, the authors made reference to the historical first use of the ergot in magic and religious rites that took place in Eleusis, at the time of classic Greece, as well as the more recent mystic use of ergot in Salem, New England, in 1692. Migraine is indeed a serious disease, frequently causing despair to the patient, who attempts to alleviate the migraneous crisis with an overdose of ergotamine. Accordingly, physicians must be aware of prophylactic vasodilating drugs, reducing the risk of ergotism.

REFERENCES

1. Aguilar-Contreras A, Zolla C: Plantas tóxicas de México. 1ª Edición. Subdirección General Médica. México, IMSS 1982: 57-59.

2. Schultes RE, Hoffman A: Plantas de los dioses. Origen y uso de los alucinógenos. México FCE 1982; 39-68, 102-105.

3. Cunningham M, de Torrenté A, Ekoé JM, Ackermann JP: Vascular spasm and gangrene during heparin-dihydroergotamine prophylaxis. Br J Surg 1984; 71: 829-831.

4. Cobaugh DS: Prazocin treatment of ergotamine induced peripheral ischemia. JAMA 1980; 244: 1360-1365.

5. Enriquez E, Velazco C, Cuevas R, Maldonado G, Bizueto H, Cruz E: Ergotismo: ¿Iatrogenia o idiosincracia? Rev Mex Angiol 1998; 26: 72-75.

6. Graves R: I: The greek myths. London, Penguin Books 1969: 89-95.

7. Garibay KAM: Mitología griega. Dioses y héroes. México Editorial Porrúa. Colección “Sepan cuantos...” 5ª Edición, 166-167.

8. Bye R, Linares E: Plantas medicinales de México prehispánico. Arqueol Mex 1999; 7: 4-11.

9. Goodman Gilman A, Rall TW: Prostaglandins, ergot, alkaloids and other drugs. Toxolytic agents. In The pharmacological basis of therapeutics. 8th Edition. New York. McGraw-Hill 1992: 933-951.

10. De Rosa G, Corsello SM, Rufilli MT: Iatrogenic arterial aneurysm associated with ergotamine therapy. Lancet 1981; 24: 934-935.

11. Seifert KB, Blackshear WM, Wayne Cruce C: Bilateral upper extremity ischemia after administration of dihydroergotamine-heparin for prophylaxis of deep venous thrombosis. J Vasc Surg 1988; 8: 410-414.

12. Richter AM, Banker PV: Carotid ergotism. A complication of therapy. Radiology 1973; 106: 171-173.

13. Greene LF, Stephan A, Stansel HC: Mesenteric and peripheral vascular ischemia secondary to ergotism. Surgery 1977; 81: 176-179.

14. Lazarides MK, Karageorgiu C, Tsiara S: Severe facial ischemia caused by ergotism. J Cardiovasc Surg 1992; 33: 383-385.

15. Jost WH, Raulf F, Muller HL: Anorectal ergotism. Induced by migraine therapy. Act Neurol Scand 1991; 84: 73-74.